Adicet bio to participate in upcoming investor conferences

Menlo park, calif. and boston, nov. 06, 2020 (globe newswire) -- adicet bio, inc. (nasdaq: acet), a biotechnology company discovering and developing first-in-class allogeneic gamma delta t cell therapies for cancer and other diseases, today announced that company management will participate in upcoming virtual investor conferences and events in november and december.
ACET Ratings Summary
ACET Quant Ranking